Literature DB >> 21114695

The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.

B Davidson1.   

Abstract

Malignant mesothelioma and ovarian/peritoneal serous carcinoma are two of the most common tumours affecting the serosal cavities. Unlike other malignant tumours diagnosed at this anatomical site, such as lung and breast carcinoma, malignant mesothelioma and serous carcinoma share a common histogenesis, may be difficult to differentiate morphologically, and co-express many of the diagnostic markers used by cytopathologists in effusion diagnosis. Selected markers have nevertheless shown sufficient sensitivity and specificity to differentiate serous carcinoma from malignant mesothelioma effectively. Recently, our group applied high throughput technology to the identification of new markers that may aid in differentiating these two cancer types and validated several of these markers in follow-up studies. This review will present current data regarding the diagnostic and biological aspects of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114695     DOI: 10.1111/j.1365-2303.2010.00829.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  12 in total

1.  Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Qianjing Hu; Yongchun Shen; Dan Xu; Tao Wang; Fuqiang Wen
Journal:  Tumour Biol       Date:  2014-03-08

2.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

3.  Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Hongyu Long; Fuqiang Wen
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

4.  Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.

Authors:  Daniel J O'Shannessy; Stephen M Jackson; Natalie C Twine; Bryan E Hoffman; Zoltan Dezso; Sergei I Agoulnik; Elizabeth B Somers
Journal:  Int J Mol Sci       Date:  2013-07-01       Impact factor: 5.923

Review 5.  Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.

Authors:  Anders Hjerpe; Valeria Ascoli; Carlos Bedrossian; Mathilde Boon; Jenette Creaney; Ben Davidson; Annika Dejmek; Katalin Dobra; Ambrogio Fassina; Andrew Field; Pinar Firat; Toshiaki Kamei; Tadao Kobayashi; Claire W Michael; Sevgen Önder; Amanda Segal; Philippe Vielh
Journal:  Cytojournal       Date:  2015-11-30       Impact factor: 2.091

6.  The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience.

Authors:  Esther Rossi; Tommaso Bizzarro; Maurizio Martini; Adhemar Longatto-Filho; Fernando Schmitt; Anna Fagotti; Giovanni Scambia; Gian Franco Zannoni
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

7.  Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status.

Authors:  Erasmia Rouka; Georgios D Vavougios; Evgeniy I Solenov; Konstantinos I Gourgoulianis; Chrissi Hatzoglou; Sotirios G Zarogiannis
Journal:  Front Physiol       Date:  2017-03-21       Impact factor: 4.566

8.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

9.  Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.

Authors:  Magnus E Jakobsson; Anders Moen; Ben Davidson; Pål Ø Falnes
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

10.  Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.

Authors:  Bo Wang; Diandian Li; Xuemei Ou; Qun Yi; Yulin Feng
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.